Jianming Pei
Shenyang Pharmaceutical University(CN)Fox Chase Cancer Center(US)Fujian Medical University(CN)China Pharmaceutical University(CN)State Grid Corporation of China (China)(CN)China University of Mining and Technology(CN)Zhejiang Ocean University(CN)Air Force Engineering University(CN)Temple University Health System(US)Medicina(PL)Changzhou No.2 People's Hospital(CN)Changzhou Third People's Hospital(CN)Huazhong University of Science and Technology(CN)University of Science and Technology Beijing(CN)Air Force Medical University(CN)
Publications by Year
Research Areas
Cardiac Ischemia and Reperfusion, Occupational and environmental lung diseases, Cancer Genomics and Diagnostics, Cardiac electrophysiology and arrhythmias, Renal cell carcinoma treatment
Most-Cited Works
- → Germline BAP1 mutations predispose to malignant mesothelioma(2011)1,068 cited
- → High‐resolution mapping of amplifications and deletions in pediatric osteosarcoma by use of CGH analysis of cDNA microarrays(2003)160 cited
- → Germline Mutation of Bap1 Accelerates Development of Asbestos-Induced Malignant Mesothelioma(2014)141 cited
- → κ- but not δ-opioid receptors mediate effects of ischemic preconditioning on both infarct and arrhythmia in rats(2001)139 cited
- → Genomic imbalances in human lung adenocarcinomas and squamous cell carcinomas(2001)110 cited
- → Bap1 Is a Bona Fide Tumor Suppressor: Genetic Evidence from Mouse Models Carrying Heterozygous Germline Bap1 Mutations(2016)105 cited